Mapping the tumor microenvironment in clear cell renal carcinoma by single-cell transcriptome analysis

Area of Science:

• Oncology
• Immunology
• Bioinformatics

Background:

• Clear cell renal cell carcinoma (ccRCC) presents unfavorable clinical outcomes.
• Intratumoral heterogeneity is critical for identifying therapeutic targets in ccRCC.
• Understanding the ccRCC tumor microenvironment (TME) is essential for treatment strategies.

Purpose of the Study:

• To elucidate intratumoral heterogeneity within the ccRCC tumor microenvironment (TME).
• To identify potential therapeutic targets for ccRCC by analyzing single-cell RNA sequencing data.
• To characterize the functional roles of diverse cell lineages within the ccRCC TME.

Main Methods:

• Bioinformatic analysis of 51,780 single cells from ccRCC and para-tumor samples.
• Identification and grouping of 11 cell lineages, including tumor cells, myeloid cells, T-cells, fibroblasts, and endothelial cells.
• Copy number variation (CNV) analysis and differential expression analysis of myeloid subgroups (monocytes, macrophages, dendritic cells).

Main Results:

• Immune cells in the TME were found to promote tumor growth and immune evasion via inflammatory suppression.
• Tumor cells exhibited significantly higher copy number variation (CNV) frequencies compared to normal cells.
• Distinct functional properties were observed among myeloid subgroups, with varied pro-tumor/immunosuppressive and antitumor/immunostimulatory roles.

Conclusions:

• This study enhances the understanding of intratumoral heterogeneity in the ccRCC TME.
• The findings highlight potential therapeutic targets for ccRCC treatment.
• Considering the diverse immune cell functions in the TME is crucial for effective ccRCC therapies.